SITE001-0099

SITE001 (USA) › SITE001-0099

SITE001-0099

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE001 (USA) · Dr. Reyes
consented 2025-12-25

enrolled

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-12-28 (study day 177); relationship: not assessed

mild assessed

Grade 3 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-08-30 (study day 57); relationship: not assessed

severe assessed

Data queries

0

No data queries. Open queries would appear here for this patient.